Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


New approach for environmental test on livestock drugs


Drugs for livestock can harm beneficial organisms that break down dung. Therefore newly developed medical substances need to be tested on single species in the lab. An international research group including evolutionary biologists from the University of Zurich have been scrutinizing the reliability of such laboratory tests, evaluating the implementation of a field test based on the anti-parasitic drug ivermectin at four climatically different locations. The scientists thus presented a novel approach for more advanced environmental compatibility tests.

Livestock medications can impair beneficial organisms that break down dung. Too high a dosage of ivermectin, a common drug against parasites, harms coprophilous organisms, for instance. The toxicity of new livestock medications therefore needs to be verified in ecotoxicological tests with individual animal species such as the common yellow dung fly, the barn fly or a dung beetle.

Dung pat with a specific concentration of ivermectin.

Image: UZH

This involves determining the lethal dose leading to the death of half the maggots (LD50 test). However, sensitivity to toxic substances is known to vary significantly even among closely related coprophilous organisms, which begs the question as to how representative the reaction of any individual animal species actually is in such laboratory tests. After all, there is a high risk that more sensitive species will continue to be harmed by the substance, jeopardizing key ecosystem functions in the long run.

An international research group including UZH evolutionary biologist Wolf Blanckenhorn recently proposed extending the testing scheme to a representative selection of all organisms that break down dung, ideally in their natural environment. The scientists now presented a successful and more comprehensive higher-tier ecotoxicological field test. Their study provides important insights into minimizing the risks of drug residues in nature.

Earthworms compensate for loss of coprophilous insects

For their feasibility study, the scientists worked on cattle pastures in the Canadian Prairie and the agricultural landscapes of southern France, the Netherlands and Switzerland – four locations with very different climatic conditions. On these pastures, they distributed dung pats with different concentrations of ivermectin. “As expected, the overall number and diversity of dung beetles, dung flies and parasitoid wasps decreased as the ivermectin concentration increased,” explains Blanckenhorn.

However, a number of species also proved to be resistant: earthworms and springtails living in the ground underneath the cowpats were not notably affected, and a parallel test ultimately revealed that dung degradation was not significantly impaired. “Evidently, beneficial organisms not affected as much by the drug, such as earthworms, were apparently able to compensate for the loss of other organisms,” sums up Blanckenhorn.

A basis for decision makers and licensing authorities

Despite diverse environmental conditions and methodological details, the results were very similar and reproducible in all four habitats. “Our field approach was therefore a success and in principle can be recommended. The regulation authorities responsible, such as the European Medicines Agency EMA, now have to decide whether this more conclusive yet more complex test should be required in the future,” says Blanckenhorn.

The amount of effort involved in determining the numerous dung organisms is tremendous and impossible without expert biological knowledge. “Classifying species via so-called DNA barcoding, based on each organism’s unique genetic fingerprint, is possible in principle and will probably be more cost-effective in the future. However, this approach requires the establishment of a complete database for coprophilous organisms, which does not yet exist,” concludes the scientist.


Kevin D. Floate, Wolf U. Blanckenhorn. Special Section: Non-target Structural and Functional Effects of Ivermectin Residues in Cattle Dung on Pasture – Guidance for Researchers and Regulators. Environmental Toxicology and Chemistry. Volume 35, Issue 8. July 21, 2016. DOI: 10.1002/etc.3549


Scientists discovered and refined ivermectin in Japan in the mid-1970s, eventually winning the Nobel Prize in Medicine in 2015. The drug has been used to cure river blindness, scabies and roundworms in the gut of humans, as well as parasites in livestock and pets.

Chemically ivermectin belongs to the avermectins, which generally interfere with ion channel transport through the cell membrane and thus the molting of pest organisms. If the ivermectin dosage is too high and excreted in the feces of treated livestock, the drug also kills beneficial organisms that break down dung. This has a negative impact on the functioning of the entire ecosystem: in extreme cases, the dung is no longer degraded at all and the pasture cannot be used any further.


Prof. Dr. Wolf U. Blanckenhorn
Department of Evolutionary Biology and Environmental Studies
University of Zurich
Phone: +41 44 635 47 55

Media Relations
University of Zurich
Phone: +41 44 634 44 67

Weitere Informationen:

Nathalie Huber | Universität Zürich

Further reports about: Ecosystem Environmental Phone animal species conditions dosage drugs earthworms fly parasites species

More articles from Ecology, The Environment and Conservation:

nachricht Dispersal of Fish Eggs by Water Birds – Just a Myth?
19.02.2018 | Universität Basel

nachricht Removing fossil fuel subsidies will not reduce CO2 emissions as much as hoped
08.02.2018 | International Institute for Applied Systems Analysis (IIASA)

All articles from Ecology, The Environment and Conservation >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

Im Focus: Surveying the Arctic: Tracking down carbon particles

Researchers embark on aerial campaign over Northeast Greenland

On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...

Im Focus: Unique Insights into the Antarctic Ice Shelf System

Data collected on ocean-ice interactions in the little-researched regions of the far south

The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...

Im Focus: ILA 2018: Laser alternative to hexavalent chromium coating

At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.

When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

TIB’s Visual Analytics Research Group to develop methods for person detection and visualisation

19.03.2018 | Information Technology

Tiny implants for cells are functional in vivo

19.03.2018 | Interdisciplinary Research

Science & Research
Overview of more VideoLinks >>>